Screener
Recursion Pharmaceuticals, Inc. RXRX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| (in thousands, except share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Numerator: | ||||
| Net loss | $(131,005) | $(171,897) | $(248,509) | $(374,384) |
| Denominator: | ||||
| Weighted average common shares outstanding | 532,460,085 | 417,361,147 | 530,890,753 | 410,268,199 |
| Net loss per share, basic and diluted | $(0.25) | $(0.41) | $(0.47) | $(0.91) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s shares (diluted)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported shares (diluted) of 532.5M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s shares (diluted) increased by 27.6% year-over-year, from 417.4M to 532.5M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s shares (diluted) has grown at a 39.3% compound annual growth rate (CAGR), from 455.3M to 1.7B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Recursion Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude